MentionFox
Home › funding signals › Cambium Biomaterials, Inc.
Company · SEC filings

Cambium Biomaterials, Inc. funding history

Before you sign with, sell to or invest in Cambium Biomaterials, Inc.

MentionFox check on Cambium Biomaterials, Inc.: only 2 sources on file so far (checked 17 November 2026). Run a full check before you rely on it. mentionfox.com/c/company/cambium-biomaterials-inc

Check Cambium Biomaterials, Inc. before you sign, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Cambium Biomaterials, Inc.?

Cambium Biomaterials, Inc. has 2 Form D filings on record, from 2023-11-14 to 2025-12-04. Together its new offerings report $111.73M sold.

Is this your company?

Funding historyFounders and team

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Cambium Biomaterials, Inc.: Raised $94.37M, Form D filed 2025-12-04
Share on LinkedIn Share on X Download image

Keep reading

More on this company and the records around it.

this company elsewhere on the record

What do you want to do with Cambium Biomaterials, Inc.?

Is Cambium Biomaterials, Inc. a real, registered company?

Cambium Biomaterials, Inc. is a registered filer with the SEC (CIK 1883516) and has filed since 2023-11-14. 2 filings are on record, the latest on 2025-12-04.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Cambium Biomaterials, Inc.?

Cambium Biomaterials, Inc.'s filings name Francisco Gimenez, Simon Waddington, Stephan Herrera and 6 more as its officers, directors or promoters.

How much has Cambium Biomaterials, Inc. raised?

Its new offerings report $111.73M sold across 2 offerings, as its own filings state.

Run the free check on Cambium Biomaterials, Inc. →

Based
El Segundo, CALIFORNIA
Industry group
Other Technology
Filings
2
Raised (new offerings)
$111.73M

Every filing

FiledTypeAmount soldTotal offeringRecords
2025-12-04New offering
first sale 2025-11-18
$94.37M$101.40Mdetails · SEC filing
2023-11-14New offering
first sale 2023-11-08
$17.36M$19.98MSEC filing

Want the whole picture on Cambium Biomaterials, Inc.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Cambium Biomaterials, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Cambium Biomaterials, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from Cambium Biomaterials, Inc.'s own filings with the SEC. The people those filings name are on the team page.

Follow this company

Tools for this story

Each opens in a new tab, filled in for Cambium Biomaterials, Inc.. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/company/cambium-biomaterials-inc
Last updated 2026-11-17
Primary record: SEC filing 1 · SEC filing 2
How much has Cambium Biomaterials, Inc. raised? $111.73M in 2 SEC filings. MentionFox, 2026-11-17. https://mentionfox.com/company/cambium-biomaterials-inc